Related Experiment Video
Updated: Jul 18, 2026

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022
Pseudomyxoma peritonei
R M Smeenk1, V J Verwaal, F A N Zoetmulder
1Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Abstract:
Pseudomyxoma peritonei (PMP) is a rare condition, which is known for its high mortality when not treated properly. The first step to improve prognosis of these patients is to recognize this clinical syndrome preferably in an early stage. Knowledge of pathogenesis and common diagnostic tools is essential in this regard. Treatment strategy for PMP should pursue complete cytoreduction and prevention of recurrence or progression. Combined modality treatment, consisting of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, seems very efficient in this regard. This approach is currently carried out in many centers throughout the world with promising results and seems to win ground as the standard treatment approach.
Insights
Pseudomyxoma peritonei (PMP) is a rare, high-mortality condition. Early recognition and complete cytoreduction via surgery and hyperthermic chemotherapy offer promising treatment outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pseudomyxoma peritonei (PMP) is a rare malignancy with high mortality if untreated.
- Early diagnosis of PMP is crucial for improving patient prognosis.
- Understanding PMP pathogenesis and diagnostic methods is essential.
Purpose of the Study:
- To highlight the importance of early recognition of PMP.
- To discuss the essential knowledge of pathogenesis and diagnostic tools for PMP.
- To present the current effective treatment strategy for PMP.
Main Methods:
- Review of PMP pathogenesis and diagnostic modalities.
- Focus on cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC).
Main Results:
- Complete cytoreduction is the primary goal in PMP treatment.
- Combined modality treatment (cytoreductive surgery + HIPEC) shows high efficiency.
- This approach is increasingly adopted globally with positive outcomes.
Conclusions:
- Early diagnosis and understanding of PMP are critical.
- Cytoreductive surgery with HIPEC is an effective treatment for PMP.
- This combined approach is becoming the standard of care for PMP.
More Related Videos
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
10:10Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Related Concept Videos
Peritoneum
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
Appendicitis
Diverticular Disease of the Colon
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.